Changes to the Medicare Advantage Program Enhance Some Consumer Protections But Roll Back Others – Image for illustrative purposes only (Image credits: Unsplash)
The Centers for Medicare & Medicaid Services finalized its Contract Year 2027 Medicare Advantage and Part D rule last month, delivering targeted improvements to how plans handle supplemental benefits alongside reductions in marketing restrictions.[1][2] Published in the Federal Register on April 6, the rule responds to industry calls for less regulatory burden while maintaining core protections for the program’s 35 million enrollees. These shifts, effective mostly for the 2027 plan year starting January 1, highlight ongoing tensions between streamlining operations and shielding beneficiaries from confusion or pressure during enrollment.
Clearer Rules for Supplemental Benefits
Plans now face stricter requirements to disclose eligibility criteria for Special Supplemental Benefits for the Chronically Ill, or SSBCI. These benefits, aimed at enrollees with serious conditions like diabetes or heart failure, must include public postings of objective standards such as health risk assessments rather than simple self-reports.[1][2] CMS expects this transparency to help beneficiaries evaluate plans more effectively before enrolling.
Debit cards used for perks like over-the-counter items or healthy food will require real-time point-of-sale verification to ensure spending stays within covered categories. Plans must also limit cards to the specific benefit year and provide clear usage guidance along with reimbursement options. These measures address past issues with misuse while preserving access.[1]
Easing Restrictions on Agents and Marketing
CMS rolled back several safeguards from recent years designed to curb aggressive sales practices. Agents no longer need to wait 48 hours after collecting a scope-of-appointment form before scheduling personal marketing meetings, and educational events can now lead directly into sales pitches with beneficiary notification.[3][2] Scope-of-appointment forms can even be gathered at those educational sessions, reversing a 2023 prohibition.
Other changes include shortening call recording retention from 10 to six years for sales interactions and dropping the ban on superlatives like “best plan” in materials, provided claims remain non-misleading. Disclaimers on calls about plan options now exclude mentions of State Health Insurance Assistance Programs, or SHIPs, focusing instead on 1-800-MEDICARE. Critics argue this diminishes access to unbiased local counseling.[4][5]
| Marketing Area | Prior Rule | 2027 Change |
|---|---|---|
| Scope-of-Appointment Wait | 48-hour delay | Eliminated |
| Educational-to-Sales Transition | 12-hour gap | Allowed with notice |
| Superlatives in Ads | Prohibited | Permitted if not misleading |
| Call Recordings | 10 years | 6 years (3 audio + 3 transcript) |
Star Ratings and Quality Tweaks
The rule removes 11 Star Ratings measures tied to administrative tasks, such as call center performance and appeals handling, where plans already showed high compliance. CMS shifted focus to clinical outcomes and patient experience, adding a new depression screening measure for 2029 ratings.[1] It also skipped a proposed health equity reward, sticking with rewards for overall high performance.
Health equity mandates faced cuts too: Plans no longer need disparity-reduction activities in quality programs or equity experts on utilization management committees. Mid-year notices about unused supplemental benefits were rescinded before taking effect, potentially leaving enrollees unaware of available perks.[5]
Broader Ramifications for Enrollees
Beneficiaries stand to gain from better insight into extras like food or transportation aid tailored for chronic conditions, reducing surprises post-enrollment. Yet relaxed marketing rules could expose seniors to more unsolicited pitches or blurred lines between information and sales, complicating choices in a market where networks cover only about half of physicians.[2]
CMS did not expand special enrollment periods for network provider losses, a missed opportunity for smoother switches. As Medicare Advantage enrollment grows amid higher plan payments projected at $13 billion more for 2027, these policies underscore a deregulatory push that prioritizes efficiency over exhaustive oversight.
In the end, the rule’s balance may streamline benefits for some while testing the resilience of existing rules against sales pressures. Beneficiaries should consult trusted resources like 1-800-MEDICARE or local SHIPs when navigating open enrollment.
